{
  "drug_name": "End_of_life_care",
  "url": "https://wikem.org/wiki/End_of_life_care",
  "scraped_at": "2026-01-10T07:52:36.614011",
  "sections": {
    "Background": {
      "text": "Despite widespread hospice services, many terminally ill patients visit the ED at the end of life (EOL)\nUp to one third of cancer patients visit the ED in the last 2 weeks of life\n[1]",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Clinical_Features": {
      "text": "Weakness\n, fatigue, and functional decline\nIncreased risk of pressure ulcers\nDecreased oral intake\nNeurologic changes\nDecreasing levels of consciousness leading to\ncoma\nand death\nTerminal\ndelirium\nconfusion, restlessness, agitation, day-night reversal\nAccumulation of upper airway secretions\nDecreased gag reflex and ability to swallow leads to gurgling, or rattling sounds with each breath\nIncontinence of urine and/or stool\nInability to close eyes\nCachexia leads to loss of retro-obital fat pad\nOphthalmic lubricants for dry eyes",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Weakness",
          "url": "https://wikem.org/wiki/Weakness"
        },
        {
          "text": "coma",
          "url": "https://wikem.org/wiki/Coma"
        },
        {
          "text": "delirium",
          "url": "https://wikem.org/wiki/Delirium"
        }
      ]
    },
    "Management": {
      "text": "Pain and dyspnea\nOpioids\nare the mainstay of treatment\nChoice of opioid based on provider preference, no trials to support one over another\nOpioid naïve patients:\nConsider starting doses of 1-2mg IV\nmorphine\nor 0.2 to 0.4mg IV\nhydromorphone\nMay safely redose in 10 minutes\nOpioid tolerant patients:\nConsider starting with 10% of total daily opioid dose\nAirway secretions\nThe “death rattle” tend to be more distressing to family members than to the patients themselves\nDiscontinue non-essential IV fluids or enteral feedings\nPosition the patient on his or her side\nGlycopyrrolate\n(0.2 mg SC q4-6hrs, or 0.2 to 0.4 mg PO q8hrs\nGenerally preferred over\natropine\nand\nscopolamine\nbecause of less central effects\nDelirium\nHaloperidol\n0.5 to 1 mg haloperidol (PO, IV, IM, or SC),  repeat dose every 45 to 60 minutes titrated against symptoms\nFor patients with persistent agitated delirium, a single dose of\nlorazepam\nmay be beneficial as an adjunct to haloperidol.",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Opioids",
          "url": "https://wikem.org/wiki/Opioids"
        },
        {
          "text": "morphine",
          "url": "https://wikem.org/wiki/Morphine"
        },
        {
          "text": "hydromorphone",
          "url": "https://wikem.org/wiki/Hydromorphone"
        },
        {
          "text": "Glycopyrrolate",
          "url": "https://wikem.org/wiki/Glycopyrrolate"
        },
        {
          "text": "atropine",
          "url": "https://wikem.org/wiki/Atropine"
        },
        {
          "text": "scopolamine",
          "url": "https://wikem.org/wiki/Scopolamine"
        },
        {
          "text": "Haloperidol",
          "url": "https://wikem.org/wiki/Haloperidol"
        },
        {
          "text": "lorazepam",
          "url": "https://wikem.org/wiki/Lorazepam"
        }
      ]
    },
    "See_Also": {
      "text": "Goals of care\nDelivering bad news",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Goals of care",
          "url": "https://wikem.org/wiki/Goals_of_care"
        },
        {
          "text": "Delivering bad news",
          "url": "https://wikem.org/wiki/Delivering_bad_news"
        }
      ]
    }
  }
}